Long-term outcomes of lercanidipine versus other calcium channel blockers in newly-diagnosed hypertension: a nationwide cohort study.
CONCLUSION: In newly diagnosed patients with hypertension, lercanidipine was superior than nifedipine in the six-year period when the analyzed endpoint was stroke.
PMID: 28300435 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research
More News: Alcoholism | Calcium | Cardiology | Cardiovascular | Databases & Libraries | Felodipine | Health Insurance | Heart | Hypertension | Insurance | Nifedipine | Norvasc | Research | Smokers | Stroke | Study